ABT vs CARR · P/E 25, rev $44.33B vs P/E 43, rev $21.75B
Abbott Laboratories (ABT) versus Carrier Global Corp (CARR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Not investment advice. Open the ABT and CARR stock pages for the full models.
Not investment advice.